Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapa
about
PI3K mutations in breast cancer: prognostic and therapeutic implicationsSignificance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast CancerBenefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms.The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis.Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.HSP60 overexpression increases the protein levels of the p110α subunit of phosphoinositide 3-kinase and c-Myc.Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer
P2860
Q28081992-E7C5766B-399E-439F-AC07-BAE641662BD1Q35801713-C995953E-8AF1-4160-ABC5-550E6EE54623Q36064908-3BF0FB88-6206-4F36-9D8A-8AC56379AC70Q37221249-DC602B40-5416-4A8D-8B15-E57A76A79958Q38812867-32E5F5C4-556C-4EBB-AC1C-FA3B6DDE4EC4Q41645967-A541B3DF-C348-4537-A24D-1E2A31CEC355Q52595390-108E0CC6-87FC-44FF-9073-3F0233F3EE6CQ54259231-525EBACC-AD95-4C2E-9CB7-541DA23AA5DDQ57494109-7365DA52-F637-4823-8B56-DCD3DBBAA5AB
P2860
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapa
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of phosphatase and ...... s treated with first-line lapa
@ast
Association of phosphatase and ...... s treated with first-line lapa
@en
Association of phosphatase and ...... s treated with first-line lapa
@nl
type
label
Association of phosphatase and ...... s treated with first-line lapa
@ast
Association of phosphatase and ...... s treated with first-line lapa
@en
Association of phosphatase and ...... s treated with first-line lapa
@nl
prefLabel
Association of phosphatase and ...... s treated with first-line lapa
@ast
Association of phosphatase and ...... s treated with first-line lapa
@en
Association of phosphatase and ...... s treated with first-line lapa
@nl
P2093
P2860
P1476
Association of phosphatase and ...... s treated with first-line lapa
@en
P2093
Catherine Ellis
Junlan Yang
Mark Russo
Meggan Leigh
Michelle DeSilvio
Zefei Jiang
Zhenzhou Shen
Zhongshen Tong
Zhongzhen Guan
P2860
P2888
P356
10.1186/S13058-014-0405-Y
P577
2014-07-24T00:00:00Z
P5875
P6179
1044669857